Patients’ Right to Know Their Medication Act of 2023

Bill 118 HR 1173, also known as the Patients' Right to Know Their Medication Act of 2023, is a piece of legislation currently being considered by the US Congress. The main purpose of this bill is to ensure that patients have access to important information about their medications in order to make informed decisions about their healthcare.

The bill requires healthcare providers to provide patients with detailed information about their medications, including the name of the medication, its purpose, potential side effects, and any alternative treatment options that may be available. This information must be provided in a clear and understandable manner, and patients must also be given the opportunity to ask questions and seek clarification about their medications.

Additionally, the bill includes provisions to improve transparency in the pharmaceutical industry. Drug manufacturers would be required to disclose information about the pricing and availability of their medications, as well as any financial relationships they may have with healthcare providers. This information would be made publicly available in order to promote greater accountability and ensure that patients are not being unduly influenced by financial incentives. Overall, the Patients' Right to Know Their Medication Act of 2023 aims to empower patients to take control of their healthcare decisions by providing them with the information they need to make informed choices about their medications. By promoting transparency and accountability in the healthcare system, this bill seeks to improve patient outcomes and ensure that individuals receive the best possible care.